Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine.
<h4>Background</h4>Non-motor symptoms (e.g., depression, anxiety, and cognitive deficits) in patients with Parkinson disease (PD) precede the onset of the motor symptoms. Although these symptoms do not respond to pharmacological dopamine replacement therapy, their precise pathological me...
Guardado en:
Autores principales: | Katsuaki Suzuki, Kyoko Okada, Tomoyasu Wakuda, Chie Shinmura, Yosuke Kameno, Keiko Iwata, Taro Takahashi, Shiro Suda, Hideo Matsuzaki, Yasuhide Iwata, Kenji Hashimoto, Norio Mori |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/87e810b085f84682b0f05795cfa6d4a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Irradiation in adulthood as a new model of schizophrenia.
por: Yasuhide Iwata, et al.
Publicado: (2008) -
Alleviation of Methamphetamine Sensitization by Partially Lesioning Dopaminergic Terminals with 6-Hydroxydopamine in Nucleus Accumbens
por: Shu-Chun Chen, et al.
Publicado: (2021) -
Dkk1 regulates ventral midbrain dopaminergic differentiation and morphogenesis.
por: Diogo Ribeiro, et al.
Publicado: (2011) -
Both Intracranial and Intravenous Administration of Functionalized Carbon Nanotubes Protect Dopaminergic Neuronal Death from 6-Hydroxydopamine
por: Kim OH, et al.
Publicado: (2020) -
Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation
por: Shane V. Hegarty, et al.
Publicado: (2017)